145 related articles for article (PubMed ID: 37229540)
1. Predicting Regioselectivity of Cytosolic Sulfotransferase Metabolism for Drugs.
Öeren M; Kaempf SC; Ponting DJ; Hunt PA; Segall MD
J Chem Inf Model; 2023 Jun; 63(11):3340-3349. PubMed ID: 37229540
[TBL] [Abstract][Full Text] [Related]
2. Updated perspectives on the cytosolic sulfotransferases (SULTs) and SULT-mediated sulfation.
Suiko M; Kurogi K; Hashiguchi T; Sakakibara Y; Liu MC
Biosci Biotechnol Biochem; 2017 Jan; 81(1):63-72. PubMed ID: 27649811
[TBL] [Abstract][Full Text] [Related]
3. Regioselective sulfation and glucuronidation of phenolics: insights into the structural basis.
Wu B; Basu S; Meng S; Wang X; Hu M
Curr Drug Metab; 2011 Nov; 12(9):900-16. PubMed ID: 21933112
[TBL] [Abstract][Full Text] [Related]
4. A comparative molecular field analysis-based approach to prediction of sulfotransferase catalytic specificity.
Sharma V; Duffel MW
Methods Enzymol; 2005; 400():249-63. PubMed ID: 16399353
[TBL] [Abstract][Full Text] [Related]
5. Structural plasticity in the human cytosolic sulfotransferase dimer and its role in substrate selectivity and catalysis.
Tibbs ZE; Rohn-Glowacki KJ; Crittenden F; Guidry AL; Falany CN
Drug Metab Pharmacokinet; 2015 Feb; 30(1):3-20. PubMed ID: 25760527
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of sulfotransferase pharmacogenetics in altered xenobiotic metabolism.
Chen BH; Wang CC; Hou YH; Mao YC; Yang YS
Expert Opin Drug Metab Toxicol; 2015 Jul; 11(7):1053-71. PubMed ID: 26073579
[TBL] [Abstract][Full Text] [Related]
7. Age-related change of hepatic uridine diphosphate glucuronosyltransferase and sulfotransferase activities in male chickens and pigs.
Hu SX
J Vet Pharmacol Ther; 2017 Jun; 40(3):270-278. PubMed ID: 27593531
[TBL] [Abstract][Full Text] [Related]
8. Sulfation of drug compounds by the zebrafish cytosolic sulfotransferases (SULTs).
Kurogi K; Dillon J; Nasser A; Liu MY; Williams FE; Sakakibara Y; Suiko M; Liu MC
Drug Metab Lett; 2010 Apr; 4(2):62-8. PubMed ID: 20446911
[TBL] [Abstract][Full Text] [Related]
9. Identification of Human UDP-Glucuronosyltransferase and Sulfotransferase as Responsible for the Metabolism of Dotinurad, a Novel Selective Urate Reabsorption Inhibitor.
Omura K; Motoki K; Kobashi S; Miyata K; Yamano K; Iwanaga T
Drug Metab Dispos; 2021 Nov; 49(11):1016-1024. PubMed ID: 34380635
[TBL] [Abstract][Full Text] [Related]
10. Functional Expression of All Human Sulfotransferases in Fission Yeast, Assay Development, and Structural Models for Isoforms SULT4A1 and SULT6B1.
Sun Y; Machalz D; Wolber G; Parr MK; Bureik M
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33171978
[TBL] [Abstract][Full Text] [Related]
11. Conjugation of catechols by recombinant human sulfotransferases, UDP-glucuronosyltransferases, and soluble catechol O-methyltransferase: structure-conjugation relationships and predictive models.
Taskinen J; Ethell BT; Pihlavisto P; Hood AM; Burchell B; Coughtrie MW
Drug Metab Dispos; 2003 Sep; 31(9):1187-97. PubMed ID: 12920175
[TBL] [Abstract][Full Text] [Related]
12. Phase II metabolism of hesperetin by individual UDP-glucuronosyltransferases and sulfotransferases and rat and human tissue samples.
Brand W; Boersma MG; Bik H; Hoek-van den Hil EF; Vervoort J; Barron D; Meinl W; Glatt H; Williamson G; van Bladeren PJ; Rietjens IM
Drug Metab Dispos; 2010 Apr; 38(4):617-25. PubMed ID: 20056724
[TBL] [Abstract][Full Text] [Related]
13. Sulfation of afimoxifene, endoxifen, raloxifene, and fulvestrant by the human cytosolic sulfotransferases (SULTs): A systematic analysis.
Hui Y; Luo L; Zhang L; Kurogi K; Zhou C; Sakakibara Y; Suiko M; Liu MC
J Pharmacol Sci; 2015 Jul; 128(3):144-9. PubMed ID: 26169578
[TBL] [Abstract][Full Text] [Related]
14. Profiles of Two Glycaemia Modifying Drugs on the Expression of Rat and Human Sulfotransferases.
Dutta SM; Chen G; Maiti S
Curr Drug Metab; 2021; 22(3):240-248. PubMed ID: 33256575
[TBL] [Abstract][Full Text] [Related]
15. Inter-donor variability of phase I/phase II metabolism of three reference drugs in cryopreserved primary human hepatocytes in suspension and monolayer.
den Braver-Sewradj SP; den Braver MW; Vermeulen NP; Commandeur JN; Richert L; Vos JC
Toxicol In Vitro; 2016 Jun; 33():71-9. PubMed ID: 26921663
[TBL] [Abstract][Full Text] [Related]
16. Sulfation through the looking glass--recent advances in sulfotransferase research for the curious.
Coughtrie MW
Pharmacogenomics J; 2002; 2(5):297-308. PubMed ID: 12439736
[TBL] [Abstract][Full Text] [Related]
17. Crystal structures of human sulfotransferases: insights into the mechanisms of action and substrate selectivity.
Dong D; Ako R; Wu B
Expert Opin Drug Metab Toxicol; 2012 Jun; 8(6):635-46. PubMed ID: 22512672
[TBL] [Abstract][Full Text] [Related]
18. Paradigms of sulfotransferase catalysis: the mechanism of SULT2A1.
Wang T; Cook I; Falany CN; Leyh TS
J Biol Chem; 2014 Sep; 289(38):26474-26480. PubMed ID: 25056952
[TBL] [Abstract][Full Text] [Related]
19. Sulfation of raloxifene and 4-hydroxytamoxifen by human cytosolic sulfotransferases.
Falany JL; Pilloff DE; Leyh TS; Falany CN
Drug Metab Dispos; 2006 Mar; 34(3):361-8. PubMed ID: 16381672
[TBL] [Abstract][Full Text] [Related]
20. Sulfation of Quercitrin, Epicatechin and Rutin by Human Cytosolic Sulfotransferases (SULTs): Differential Effects of SULT Genetic Polymorphisms.
Mei X; Gohal SA; Alatwi ES; Hui Y; Yang C; Song Y; Zhou C; Liu MC
Planta Med; 2021 May; 87(6):498-506. PubMed ID: 33572003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
